文献速递心血管CT

超高清光子计数探测器CT冠状动脉造影评估冠状动脉疾病狭窄

Ultrahigh-Spatial-Resolution Photon-counting Detector CT Angiography of Coronary Artery Disease for Stenosis Assessment.
PubMed 文献 · Radiology · 2024-01-01

本研究通过体外血管模型和114例患者回顾性评估超高清光子计数探测器CT对冠状动脉狭窄的影响,发现钙化狭窄的直径狭窄百分比随空间分辨率提高而降低,超高清重建使54.4%患者CAD-RADS分类降级。

要点

  • 钙化狭窄的直径狭窄百分比随空间分辨率提高而降低,超高清重建较标准重建更低。
  • 超高清重建使54.4%患者CAD-RADS分类较标准重建降级。
  • 非钙化和混合斑块的直径狭窄百分比在不同重建间无显著差异。

核心结论

  • 超高清光子计数探测器CT重建改善了钙化狭窄的评估,导致更低的直径狭窄百分比和临床相关的CAD-RADS降级。

研究设计与样本

  • 前瞻性体外血管模型(含25%和50%两处狭窄)及回顾性患者研究(2022年7月至2023年4月,114例,平均年龄68岁±9,71例男性),重建标准分辨率(层厚0.6 mm,增量0.4 mm,Bv44卷积核)、高空间分辨率(层厚0.4 mm,增量0.2 mm,Bv44卷积核)和超高清空间分辨率(层厚0.2 mm,增量0.1 mm,Bv64卷积核)。

关键影像表现/征象

  • 钙化狭窄(n=161)的直径狭窄百分比中位数随空间分辨率提高而降低:标准分辨率41.5%(IQR 27.3%-58.2%),高空间分辨率34.8%(IQR 23.7%-55.1%),超高清空间分辨率26.7%(IQR 18.6%-44.3%),P < .001。
  • 非钙化斑块(n=13)和混合斑块(n=19)的直径狭窄百分比在不同重建间无显著差异(P ≥ .88)。

诊断标准与关键数值

  • 体外模型直径狭窄百分比测量的平均偏差:标准分辨率10.1%,高空间分辨率8.0%,超高清空间分辨率2.3%,P < .001。
  • 超高清重建使62/114(54.4%)患者CAD-RADS分类较标准分辨率降级。

临床应用与阅片要点

  • 超高清光子计数探测器CT重建可用于钙化狭窄的评估,降低直径狭窄百分比并导致CAD-RADS降级。
  • 非钙化和混合斑块的狭窄评估在不同重建间无显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Coronary CT angiography is a first-line test in coronary artery disease but is limited by severe calcifications. Photon-counting-detector (PCD) CT improves spatial resolution. Purpose To investigate the effect of improved spatial resolution on coronary stenosis assessment and reclassification. Materials and Methods Coronary stenoses were evaluated prospectively in a vessel phantom (in vitro) containing two stenoses (25%, 50%), and retrospectively in patients (in vivo) who underwent ultrahigh-spatial-resolution cardiac PCD CT (from July 2022 to April 2023). Images were reconstructed at standard resolution (section thickness, 0.6 mm; increment, 0.4 mm; Bv44 kernel), high spatial resolution (section thickness, 0.4 mm; increment, 0.2 mm; Bv44 kernel), and ultrahigh spatial resolution (section thickness, 0.2; increment, 0.1 mm; Bv64 kernel). Percentages of diameter stenosis (DS) were compared between reconstructions. In vitro values were compared with the manufacturer specifications of the phantom and patient results were assessed regarding effects on Coronary Artery Disease Reporting and Data System (CAD-RADS) reclassification. Results The in vivo sample included 114 patients (mean age, 68 years ± 9 [SD]; 71 male patients). In vitro percentage DS measurements were more accurate with increasing spatial resolution for both 25% and 50% stenoses (mean bias for standard resolution, high spatial resolution, and ultrahigh spatial resolution, respectively: 10.1%, 8.0%, and 2.3%; P < .001). In vivo results confirmed decreasing median percentage DS with increasing spatial resolution for calcified stenoses (n = 161) (standard resolution, high spatial resolution, and ultrahigh spatial resolution, respectively: 41.5% [IQR, 27.3%-58.2%], 34.8% [IQR, 23.7%-55.1%], and 26.7% [IQR, 18.6%-44.3%]; P < .001), whereas noncalcified (n = 13) and mixed plaques (n = 19) did not show evidence of a difference (P ≥ .88). Ultrahigh-spatial-resolution reconstructions led to reclassification of 62 of 114 (54.4%) patients to lower CAD-RADS category than that assigned using standard resolution. Conclusion In vivo and in vitro coronary stenosis assessment improved for calcified stenoses by using ultrahigh-spatial-resolution PCD CT reconstructions, leading to lower percentage DS compared with standard resolution and clinically relevant rates of reclassification. © RSNA, 2024 Supplemental material is available for this article. See also the editorial by McCollough in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Halfmann MC, Bockius S, Emrich T, et al. Ultrahigh-Spatial-Resolution Photon-counting Detector CT Angiography of Coronary Artery Disease for Stenosis Assessment. Radiology. 2024. PMID: 38376407. doi:10.1148/radiol.231956

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。